- Home
- Who We Are
About Us
Qu Biologics has attracted a team of life sciences professionals who are leaders in their respective fields.
- What We Do
What We Do
Qu Biologics’ SSIs restore innate immune function and reverse the chronic inflammation underlying many conditions such as cancer and immune-related disease.
- Clinical Trials
Clinical Trials
Investigational treatment QBECO SSI is an immunotherapy aimed at restoring normal immune function to reverse the chronic inflammation underlying Crohn’s disease.
- Partner With Us
Partner With Us
To gain a better understanding of the root causes of disease and the potential benefits of novel immunotherapies, Qu Biologics has a number of university research collaborations.
- Qu In The News
- Careers
Careers
Join a team of innovators who have a passion to make a difference. In a short time, our ambitious team has achieved a number of major milestones and we have many big goals ahead.
- Contact Us
Pipeline
Qu Biologics has developed a platform of Site Specific Immunomodulators (SSIs) with the goal of stimulating recruitment of activated macrophages to a targeted diseased organ or tissue to restore normal immune function. Read How SSIs Work.
Each SSI is derived from components of a single inactivated bacterial species that is a common cause of infection in the targeted organ or tissue. Administered by simple subcutaneous injection, SSIs are designed to restore normal immune function in the targeted organ and reverse the chronic inflammation underlying cancer and immune-related diseases, such as Crohn’s disease and ulcerative colitis. Read Efficacy and Safety.
Qu Biologics’ Platform of Investigational Site Specific Immunomodulators (SSIs)
